Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 3/2020

08.11.2019 | Case Report

A rectal neuroendocrine tumor in a patient with Crohn’s disease: a case report and literature review

verfasst von: Katsunori Suzuki, Masayoshi Yamamoto, Yuhi Suzuki, Takafumi Kawamura, Megumu Kamishima, Mayu Sakata, Takashi Harada, Takuma Kagami, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Satoshi Osawa, Ken Sugimoto, Kiyotaka Kurachi, Hiroya Takeuchi

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Crohn’s disease is recognized to increase the risk of gastrointestinal malignances. Adenocarcinoma is the most common malignancy in these patients. Association between Crohn’s disease and adenocarcinoma in the small intestine has already been established, however, the association between neuroendocrine tumor and Crohn’s disease remains uncertain. We report a 39-year-old man with Crohn’s disease, who was diagnosed with NET in the rectum. He had suffered from fever and anal pain due to the anal fistula and abscess. The disease state was considered to be resistant to medical treatment. He underwent total proctocolectomy, small bowel resection, anal fistula drainage with ileostomy. Postoperative histology revealed a neuroendocrine tumor in the rectum. His postoperative course was uneventful, and he followed a good course under treatment with infliximab and mercaptopurine hydrate. This case highlights the need of careful observation of resected specimens in light of the possibility of NET, especially those with anal disorders.
Literatur
1.
Zurück zum Zitat Savoca PE, Ballantyne GA, Cahow CE. Gastrointestinal malignancies in Crohn’s disease, a 20 year experience. Dis Colon Rectum. 1990;33:7–11.CrossRefPubMed Savoca PE, Ballantyne GA, Cahow CE. Gastrointestinal malignancies in Crohn’s disease, a 20 year experience. Dis Colon Rectum. 1990;33:7–11.CrossRefPubMed
2.
Zurück zum Zitat Owzarek D, Cibor D, Szczepanski W, et al. Concomitant carcinoid tumor and papillary urothelial neoplasm of low malignant potential in a patient with Crohn’s disease: a case report. Eur J Gastroenterol Hepatol. 2008;20(12):1231–4.CrossRef Owzarek D, Cibor D, Szczepanski W, et al. Concomitant carcinoid tumor and papillary urothelial neoplasm of low malignant potential in a patient with Crohn’s disease: a case report. Eur J Gastroenterol Hepatol. 2008;20(12):1231–4.CrossRef
3.
Zurück zum Zitat Stout AP. Carcinoid tumors of the rectum derived from Erspamer’s pre-enterochrome cells. Am J Pathol. 1942;18:993–1009.PubMedPubMedCentral Stout AP. Carcinoid tumors of the rectum derived from Erspamer’s pre-enterochrome cells. Am J Pathol. 1942;18:993–1009.PubMedPubMedCentral
4.
Zurück zum Zitat Villote J, Mouchet A, Martin E, et al. Crohn’s disease revealed by a vesico-intestinal fistula and associated with a carcinoid tumor of the small intestine. Sem Hop Paris. 1969;45:1620–5. Villote J, Mouchet A, Martin E, et al. Crohn’s disease revealed by a vesico-intestinal fistula and associated with a carcinoid tumor of the small intestine. Sem Hop Paris. 1969;45:1620–5.
5.
Zurück zum Zitat Wood WJ, Archer R, Schaefner JW, et al. Coexistence of regional enteritis and carcinoid tumor. Gastroenterology. 1970;59:265–9.CrossRefPubMed Wood WJ, Archer R, Schaefner JW, et al. Coexistence of regional enteritis and carcinoid tumor. Gastroenterology. 1970;59:265–9.CrossRefPubMed
6.
Zurück zum Zitat Tehrani MA, Carface DC. Carcinoid tumor and Crohn’s disease. Br J Clin Prac. 1975;29:123–4. Tehrani MA, Carface DC. Carcinoid tumor and Crohn’s disease. Br J Clin Prac. 1975;29:123–4.
7.
Zurück zum Zitat Feldman CH, Stavorovsky MM, Schuman E, et al. Regional enteritis, thymoma and multiple carcinoids: an unusual association. Int Surg. 1980;65:63–5. Feldman CH, Stavorovsky MM, Schuman E, et al. Regional enteritis, thymoma and multiple carcinoids: an unusual association. Int Surg. 1980;65:63–5.
8.
Zurück zum Zitat Janin Y, Schwartz D, Becker JM, et al. Crohn’s disease and carcinoid tumor of the appendix in a child. Z Kinderchir. 1981;4:376–69. Janin Y, Schwartz D, Becker JM, et al. Crohn’s disease and carcinoid tumor of the appendix in a child. Z Kinderchir. 1981;4:376–69.
9.
Zurück zum Zitat Van Lindingham SB, Kluppel S, Symmonds R, et al. Coexistence carcinoid tumor and Crohn’s disease. J Surr Oncol. 1983;24:310–4.CrossRef Van Lindingham SB, Kluppel S, Symmonds R, et al. Coexistence carcinoid tumor and Crohn’s disease. J Surr Oncol. 1983;24:310–4.CrossRef
10.
Zurück zum Zitat Brown GA, Kollin J, Rajan RK. The coexistence of carcinoid tumor and Crohn’s disease. J Clin Gastroenterol. 1986;8:286–9.CrossRefPubMed Brown GA, Kollin J, Rajan RK. The coexistence of carcinoid tumor and Crohn’s disease. J Clin Gastroenterol. 1986;8:286–9.CrossRefPubMed
11.
Zurück zum Zitat Kosakowski C, Thompson JE, Feinberg MJ. Coexistence of primary Crohn’s disease and carcinoid tumor isolated to the appendix. Acta Chir Scand. 1986;152:233–6.PubMed Kosakowski C, Thompson JE, Feinberg MJ. Coexistence of primary Crohn’s disease and carcinoid tumor isolated to the appendix. Acta Chir Scand. 1986;152:233–6.PubMed
12.
Zurück zum Zitat Bauer T. Karcinoid og mb. Crohn i appendix. Ugeskr Laeger. 1986;148:1091–2.PubMed Bauer T. Karcinoid og mb. Crohn i appendix. Ugeskr Laeger. 1986;148:1091–2.PubMed
13.
14.
Zurück zum Zitat Kortbeek J, Kelly JK. Carcinoid tumor and inflammatory bowel disease. J Surg Oncol. 1992;49:122–6.CrossRefPubMed Kortbeek J, Kelly JK. Carcinoid tumor and inflammatory bowel disease. J Surg Oncol. 1992;49:122–6.CrossRefPubMed
15.
Zurück zum Zitat Hock YL, Scott KW, Grace RH. Mixed adenocarcinoma/carcinoid tumour of large bowel in a patient with Crohn’s disease. J Clin Pathol. 1993;24:310–4. Hock YL, Scott KW, Grace RH. Mixed adenocarcinoma/carcinoid tumour of large bowel in a patient with Crohn’s disease. J Clin Pathol. 1993;24:310–4.
16.
Zurück zum Zitat LeMarc’hadour F, Bost F, Peoc’h M, et al. Carcinoid tumor complicating of the literature. Pathol Res Pract. 1994;190:1185–92.CrossRef LeMarc’hadour F, Bost F, Peoc’h M, et al. Carcinoid tumor complicating of the literature. Pathol Res Pract. 1994;190:1185–92.CrossRef
17.
Zurück zum Zitat Greenstein AJ, Balasubramanian S, Harpaz N, et al. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol. 1997;92(4):682–5.PubMed Greenstein AJ, Balasubramanian S, Harpaz N, et al. Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol. 1997;92(4):682–5.PubMed
18.
Zurück zum Zitat Hamaguti Y, Obi Y, Wada J, et al. Two cases of inflammatory bowel diseases associated with gastrointestinal carcinoids. Jpn J Gastroenterogical Surg. 1997;30(10):2039–43.CrossRef Hamaguti Y, Obi Y, Wada J, et al. Two cases of inflammatory bowel diseases associated with gastrointestinal carcinoids. Jpn J Gastroenterogical Surg. 1997;30(10):2039–43.CrossRef
19.
Zurück zum Zitat Auber F, Gambiez L, Desreumaux P, et al. Mixed adenocarcinoid tumor and Crohn’s disease. J Clin Gastroenterol. 1998;26:353–4.CrossRefPubMed Auber F, Gambiez L, Desreumaux P, et al. Mixed adenocarcinoid tumor and Crohn’s disease. J Clin Gastroenterol. 1998;26:353–4.CrossRefPubMed
20.
Zurück zum Zitat Cioffi U, De Simone M, Ferrero S, et al. Synchronous adenocarcinoma and carcinoid tumor of the terminal ileum in a Crohn’s disease patient. BMC. 2005;5:157. Cioffi U, De Simone M, Ferrero S, et al. Synchronous adenocarcinoma and carcinoid tumor of the terminal ileum in a Crohn’s disease patient. BMC. 2005;5:157.
21.
Zurück zum Zitat Hazzan D, Eckstein JG, Steinhagen R. Carcinoid tumor and Crohn’s ileitis. Isr Med Assoc J. 2005;7:264. Hazzan D, Eckstein JG, Steinhagen R. Carcinoid tumor and Crohn’s ileitis. Isr Med Assoc J. 2005;7:264.
22.
Zurück zum Zitat Hwang H, Doyle J, Chai B, et al. Incidental malignant carcinoid within Crohn ileitis. Can J Surg. 2009;52(3):E58–59.PubMedPubMedCentral Hwang H, Doyle J, Chai B, et al. Incidental malignant carcinoid within Crohn ileitis. Can J Surg. 2009;52(3):E58–59.PubMedPubMedCentral
23.
Zurück zum Zitat Boltin D, Levi Z, Halpern M, et al. Concurrent small bowel adenocarcinoma and carcinoid tumor in Chrohn’s disease-Case report and literature review. J Crohns Colitis. 2011;5:461–4.CrossRefPubMed Boltin D, Levi Z, Halpern M, et al. Concurrent small bowel adenocarcinoma and carcinoid tumor in Chrohn’s disease-Case report and literature review. J Crohns Colitis. 2011;5:461–4.CrossRefPubMed
24.
Zurück zum Zitat Praticò C, Rizzelo F, Fornarini GS, et al. Four cases of carcinoid tumor in Crohn’s disease: coincidence or correlation? Int J Colorectal Dis. 2013;28:1743–5.CrossRefPubMed Praticò C, Rizzelo F, Fornarini GS, et al. Four cases of carcinoid tumor in Crohn’s disease: coincidence or correlation? Int J Colorectal Dis. 2013;28:1743–5.CrossRefPubMed
25.
Zurück zum Zitat Mogollon M, Conde R, Segura I. Ileal carcinoid tumor within Crohn’s disease. Rev Esp Enferm Dig. 2014;106:298–9.PubMed Mogollon M, Conde R, Segura I. Ileal carcinoid tumor within Crohn’s disease. Rev Esp Enferm Dig. 2014;106:298–9.PubMed
26.
Zurück zum Zitat Pellino G, Marcellinaro R, Candilio G, et al. The experience of a referral centre and literature overview of GIST and carcinoid tumours in inflammatory bowel diseases. Int J Surg. 2016;28:S133–S141141.CrossRefPubMed Pellino G, Marcellinaro R, Candilio G, et al. The experience of a referral centre and literature overview of GIST and carcinoid tumours in inflammatory bowel diseases. Int J Surg. 2016;28:S133–S141141.CrossRefPubMed
27.
Zurück zum Zitat Dörfell Y, Swiidsinski A, Loening-Baucke V, et al. Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn’s disease and effect of therapy. Inflamm Bowel Dis. 2012;18:1663–711.CrossRef Dörfell Y, Swiidsinski A, Loening-Baucke V, et al. Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn’s disease and effect of therapy. Inflamm Bowel Dis. 2012;18:1663–711.CrossRef
28.
Zurück zum Zitat Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomark Prev. 1994;3(3):205–7. Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomark Prev. 1994;3(3):205–7.
Metadaten
Titel
A rectal neuroendocrine tumor in a patient with Crohn’s disease: a case report and literature review
verfasst von
Katsunori Suzuki
Masayoshi Yamamoto
Yuhi Suzuki
Takafumi Kawamura
Megumu Kamishima
Mayu Sakata
Takashi Harada
Takuma Kagami
Shinya Tani
Mihoko Yamade
Yasushi Hamaya
Satoshi Osawa
Ken Sugimoto
Kiyotaka Kurachi
Hiroya Takeuchi
Publikationsdatum
08.11.2019
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 3/2020
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01063-w

Weitere Artikel der Ausgabe 3/2020

Clinical Journal of Gastroenterology 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.